authors
- Djalalov, S
- Beca, J
- Hoch, JS
- Krahn, MD
- Tsao, MS
- Cutz, Jean-claude
- Leighl, N
Cost-Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients with Advanced ALK Positive Non-Small Cell Lung Cancer in a Publicly Funded System (Ontario, Canada)
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 2013
has subject area
- 1117 Public Health and Health Services (FoR)
- 1402 Applied Economics (FoR)
- Health Policy & Services (Science Metrix)
published in
- Value in Health Journal